The availability of biosimilars commonly used to treat moderate to severe RA may not by itself reduce out-of-pocket costs for Medicare beneficiaries due to a lack of manufacturer discounts.

Genetic mutations in a form of non–small cell lung cancer may drive tumor formation by blurring cells’ perception of key growth signals, according to a new laboratory study published Aug. 31, 2018, in Science.

The Resource Allocation Program (RAP), in partnership with many on-campus sources of research funding, facilitates the dissemination, submission, review and award of intramural research funding opportunities on campus.

Researchers at UCSF and the Gladstone Institutes have received an $18 million grant from the National Institutes of Health to launch the Psychiatric Cell Map Initiative.

Thanks to a $6.7 million grant, the newly named UCSF-Stanford Pediatric Device Consortium can focus on the development of revolutionary, low-cost gadgets to diagnose and cure pediatric health conditions.

As the low-carbohydrate, high-fat ketogenic, or “keto,” diet becomes more popular, scientists at UCSF are among those working to study its potential health benefits and risks.

By creating a tailored drug cocktail that matches the mutations of a brain tumor, a new precision medicine approach may move the needle for children with high-grade gliomas.

UCSF Benioff Children’s Hospitals are part of a nationwide campaign to shine a spotlight on childhood cancer during Pediatric Cancer Awareness Month in September—with the color gold as the campaign’s symbol.